This achievement is the result of over fifteen years of research, is directed toward the system related to the tumor and does not cause severe side effects, according to the specialists / The vaccine can be used as a treating "chronic increases expectations and quality of life of patients"
Cuba registered the first therapeutic vaccine for advanced lung cancer in the world, named CIMAVAX-EGF, with which they have been treated over thousand patients on the island, said Monday representatives of the weekly "Workers." The head of
project of this vaccine in the Molecular Immunology Center (CIM) in Havana, Gisela González, explained that provides the ability to turn advanced cancer in a "manageable chronic disease."
CIMAVAX-EGF is the result of over fifteen years of research, is directed toward the system related to the tumor and does not cause severe side effects, said the specialist.
"is based on a protein that we all have: the epidermal growth factor, related to the processes of cell proliferation, that when there are cancer control", he said.
Gonzalez said that because the body tolerates "the itself "and react against" strange ", so had to make" a composition that achieves generate antibodies against this protein. "
This vaccine is given at the time in which the patient finds treatment with radiotherapy or chemotherapy and is considered "terminal without alternative therapy" because it helps "control the growth of the tumor without associated toxicity, he said.
can also be used as a treatment "chronic increases expectations and quality of life for patients."
The researcher noted that after reaching its record in Cuba, now CIMAVAX-EGF "progress" in other countries and evaluates ways to use its inception in therapies against other tumors such as prostate, uterus and breast.
0 comments:
Post a Comment